Literature DB >> 22009996

Validation of doripenem dosing in patients with end-stage renal disease receiving hemodialysis.

Emily L Heil, Lindsay M Daniels, Christine M Walko, David P Nicolau, Edwin A Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22009996     DOI： 10.1345/aph.1Q395

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  1 in total

1.  Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy.

Authors:  M G Vossen; L Ehmann; S Pferschy; A Maier-Salamon; M Haidinger; C Weiser; J M Wenisch; K Saria; C Kajahn; S Jilch; R Lemmerer; M Bécède; M Zeitlinger; C Kloft; W Jäger; F Thalhammer
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.